Effect of short and long term antibiotic response on lung function in bronchiectasis

Area of Science:

• Pulmonology
• Respiratory Medicine
• Infectious Disease

Background:

• Bronchiectasis is a chronic lung condition characterized by persistent purulent bronchial secretions.
• The reversibility of lung damage caused by purulent secretions is not well understood.
• Chronic bronchial sepsis may lead to irreversible pulmonary changes.

Purpose of the Study:

• To investigate whether purulent bronchial secretions cause reversible or irreversible lung damage in patients with bronchiectasis.
• To assess the impact of converting purulent sputum to mucoid sputum using antibiotics on lung function.

Main Methods:

• Lung function tests were performed on 18 patients with bronchiectasis before and after two weeks of antibiotic treatment.
• Ten patients underwent further lung function tests after four months of antibiotic treatment.
• Sputum characteristics (purulent vs. mucoid) were monitored throughout the study.

Main Results:

• A small, statistically significant improvement in lung function indices (FEV1, FVC, VC, FRC, TLC) was observed after two weeks of antibiotic treatment.
• After four months, only forced vital capacity (FVC) remained significantly improved compared to baseline in the subgroup studied.
• The observed improvements were not clinically significant, contrasting with findings from previous studies.

Conclusions:

• The limited and transient improvements in lung function suggest that the physiological abnormalities in bronchiectasis with chronic bronchial sepsis are largely irreversible.
• The findings highlight the persistent nature of lung damage in this patient population.
• Further research may be needed to explore interventions that could potentially reverse or mitigate these chronic changes.